πŸ§ͺ HPLC Verified β€” β‰₯99% Purity Guaranteed🚚 Free Shipping on Orders Over $200πŸ‡ΊπŸ‡Έ 100% USA Manufactured & SourcedπŸ“„ COA Available for Every Batchβœ… Third-Party Tested for Purity & Identityβš—οΈ New Arrivals β€” Shop the Latest Research CompoundsπŸ§ͺ HPLC Verified β€” β‰₯99% Purity Guaranteed🚚 Free Shipping on Orders Over $200πŸ‡ΊπŸ‡Έ 100% USA Manufactured & SourcedπŸ“„ COA Available for Every Batchβœ… Third-Party Tested for Purity & Identityβš—οΈ New Arrivals β€” Shop the Latest Research Compounds
Homeβ€ΊShopβ€ΊIpamorelin
Ipamorelin
COA Coming Soon β€” View COA Directory
Peptides

Quantity

$59.99

Ipamorelin is a selective growth hormone secretagogue peptide studied for GH pulse stimulation with minimal side-effect profile in research.

⚠️ For research purposes only. Not for human consumption. By purchasing you confirm you are a qualified researcher.

Ipamorelin Overview

Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist. It is studied in preclinical and experimental research for its selective pituitary signaling activity with minimal off-target pathway interference. This selectivity makes it an important tool for investigating endocrine signaling, somatotroph axis modulation, and related molecular pathways.

Ipamorelin Structure

Ipamorelin molecular structure

CAS #: 170851-70-4

Molecular Formula: Cβ‚ƒβ‚ˆH₄₉N₉Oβ‚…

Molecular Weight: 711.9 g/mol

PubChem ID: 9831659

Research Findings

Ipamorelin has been studied in endocrine, metabolic, and regenerative models, with research highlighting its activity in stimulating growth hormone release, modulating IGF-1 pathways, and supporting tissue recovery processes. Studies have also examined its role in metabolic regulation, energy balance, and cellular repair in preclinical systems.

Key Areas of Research:

  • Endocrine: Somatotroph axis, signaling, cascadesSignaling: Systemic markers, pathway dynamicsMolecular: Remodeling, proliferation, viabilityTogether, these findings suggest experimental utility for Ipamorelin across multiple biological pathways. By influencing endocrine signaling and downstream remodeling processes, Ipamorelin provides a versatile platform for research into pathway dynamics, endocrine activity, and systemic resilience in laboratory settings.Raun K. et al., 1998

References

Svensson J. et al. (1998). Ipamorelin selectively stimulates GH release in humans without affecting cortisol or prolactin. J Clin Endocrinol Metab, 83(9):3094–3101. Bowers C.Y. et al. (1997). Ipamorelin: a novel pentapeptide GH secretagogue. Endocrinology, 138(9): 4011–4016. Culler M.D. et al. (2002). Pharmacological characterization of Ipamorelin, a GHRP with GH selectivity. J Endocrinol, 174(2):R1–R6. 

Same Category

Related Compounds